LY6D and neoplasm: LY6D may modulate the expression of the Taut, thereby affecting the uptake of taurine by tumor cells, altering the intracellular taurine levels in tumor cells, and ultimately influencing the proliferative, survival, and immune escape capabilities of tumor cells (37).